3D Tumour Atlases Revolutionize Cancer Detection & Treatment
Publication Title: 3D multi-omics tumour atlases: from technology to biology and clinical translation
Summary
- Question
- This review examines the development of 3D multi-omics tumor atlases, focusing on how emerging technologies can provide a comprehensive understanding of tumor evolution and its complex interactions within a three-dimensional space. The authors explore tools and approaches for constructing these atlases and their potential applications in cancer biology and clinical practice.
- Why it Matters
- Cancer is one of the leading causes of death worldwide, and its progression involves highly complex interactions among different cell types within tumors and their surrounding environments. Traditional methods often fail to capture this complexity. By mapping tumors in 3D and integrating multi-omics data—information about genes, proteins, and other molecular factors—researchers aim to uncover new biomarkers for early detection, risk assessment, and targeted treatments. These advancements could transform cancer diagnostics, improve treatment strategies, and lead to better patient outcomes.
- Methods
- The authors reviewed emerging technologies in spatial multi-omics, which combine data from multiple biological layers, such as genetics and proteomics (the study of proteins). They discussed tools developed both within and beyond the tumor atlas research community, focusing on their ability to analyze cellular and molecular interactions in a three-dimensional space. The review highlights efforts to track tumor evolution over time and within spatial contexts, emphasizing holistic approaches rather than isolated observations.
- Key Findings
- The researchers identified that 3D tumor atlases offer a unique perspective on the dynamic ecosystem of tumors, revealing how they evolve from precancerous lesions to metastasis. These atlases provide detailed insights into molecular and cellular mechanisms, including interactions between cancer cells and their microenvironments. They emphasized the potential of these tools to identify novel biomarkers—biological indicators used for disease detection and prognosis—and to improve early intervention strategies.
- Implications
- The creation of 3D multi-omics tumor atlases could revolutionize cancer research and clinical care. By providing a deeper understanding of tumor biology, these atlases could enhance the ability to detect cancer early, predict its progression, and personalize treatments. They may also guide the development of preventive measures and new therapies, offering hope for more effective management of this disease.
- Next Steps
- The authors suggest further refinement of spatial multi-omics technologies to improve data accuracy and integration. They call for collaboration between researchers to expand the tumor atlas community and explore its applications in various cancer types. Future research should also focus on translating these findings into clinical practice to benefit patients directly.
- Funding Information
- This research was supported by the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Yale University also provided funding and support for this research.
Full Citation
Liu M, Villazon J, Forjaz A, Tian X, Fan R, Wang S, Shi L, Wirtz D, Kiemen A. 3D multi-omics tumour atlases: from technology to biology and clinical translation. Nature Reviews Cancer 2026, 1-28. PMID: 42298141, DOI: 10.1038/s41568-026-00940-0.
This AI-assisted summary has been reviewed and approved by at least one of the study's authors to ensure it accurately reflects the research.
Authors
Miao Liu
First AuthorAshley L. Kiemen
Last Author
Yale School of Medicine Authors
Other Authors
Research Themes
Concepts
- development of pre-malignant lesions;
- tumor evolution;
- pre-malignant lesions;
- risk stratification;
- precancerous lesions;
- treatment strategies;
- tumor initiation;
- human tumors;
- tumor;
- clinical translation;
- cancer biology;
- cellular mechanisms;
- spatial multi-omics;
- early detection;
- cell types;
- Multi-Omics;
- lesions;
- cancer;
- preventive interventions